查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594379

多組體學市場：按產品類型、應用和最終用戶分類 - 2025-2030 年全球預測

Multiomics Market by Product (Consumables, Instrument, Software), Type (Epigenomics, Genomics, Metabolomics), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年多組體學市場價值為835.5億美元，預計到2024年將達到968.6億美元，複合年成長率為16.26%，到2030年將達到2399.2億美元。

多體學是生物研究領域的綜合辦法，它整合了基因組學、轉錄組學、蛋白質組學和代謝體學等多種「體學」技術，以全面了解細胞、組織和生物體的分子組成。對多組體學的需求源於生物系統的複雜性以及了解不同分子成分如何相互作用以及如何影響健康和疾病狀態的需要。應用範圍廣泛，包括個人化醫療、生物標記發現、藥物開發和農業。

主要市場統計
基準年[2023] 835.5億美元
預測年份 [2024] 968.6億美元
預測年份 [2030] 2399.2億美元
複合年成長率（%） 16.26%

研究範圍包括製藥和生物技術公司、研究機構、醫院和診所。多體學在藥物發現和治療開發中發揮關鍵作用，可以實現更有針對性的治療和個人化治療計劃，並且對精準醫學的進步至關重要。此外，它還有助於農業生物技術，改善作物育種和提高抵禦能力，為糧食安全做出重大貢獻。

促進市場開拓的因素包括體學技術的進步、研發投資的增加、慢性病的流行以及對個人化醫療的日益重視。對精準醫療、新興市場不斷成長的需求以及多組體學資料和人工智慧的整合以增強分析可以找到關鍵機會。學術機構和生技公司之間不斷加強的夥伴關係也可能產生巨大的推動作用。

然而，市場成長面臨挑戰，例如與體學技術相關的高成本、複雜的資料解釋以及對先進生物資訊學專業知識的需求。隱私問題和監管限制使研究和應用更加複雜。

創新和研究可以集中在開發更具成本效益和可擴展的體學技術、改進資料整合方法以及增強生物資訊學工具以更好地進行資料分析。這些細分市場的最佳化預計將解決現有挑戰並促進市場擴張。儘管市場競爭激烈，但透過關注系統生物學等新興領域、促進跨部門合作、匯集專業知識和利用新興技術，仍存在巨大的成長潛力。

市場動態：揭示快速發展的多組體學市場的關鍵市場洞察

供給和需求的動態交互作用正在改變多組體學市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • NGS、基於質譜的蛋白質組學和基因表現平台的不斷進步
    • 由於對個人化醫療的日益偏好，潛力巨大
    • 活性化生物技術公司的研究和開發
  • 市場限制因素
    • 與多組體學相關的高成本且專家技術有限
  • 市場機會
    • 加強先進技術與多組體學的整合
    • 增加對農業研究和環境科學的投資以實現永續性目標
  • 市場問題
    • 體學研究中資料收集、儲存和共用的標準通訊協定有限

波特的五力：駕馭體學市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解多組體學市場的外部影響

外部宏觀環境因素在塑造多組體學市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解多體學市場的競爭格局

對多組體學市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：多體學市場供應商的績效評估

FPNV定位矩陣是評估多組體學市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製多體學市場的成功之路

多組體學市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • NGS、質譜特異性蛋白質體學和基因表現平台的進展
      • 由於對個人化藥物的日益偏好，潛力巨大
      • 生技公司的研發活動增加
    • 抑制因素
      • 與多組體學相關的高成本且專家技術有限
    • 機會
      • 擴大先進技術與多組體學的整合
      • 增加對農業研究和環境科學的投資以實現永續性目標
    • 任務
      • 體學研究中資料收集、儲存和共用的標準通訊協定有限
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章 多組體學市場：依產品

  • 介紹
  • 消耗品
  • 裝置
  • 軟體

第 7 章 多組體學市場：按類型

  • 介紹
  • 表觀基因
  • 基因組學
  • 代謝體學
  • 微生物組學
  • 蛋白質體學
  • 轉錄組學

第 8 章 多組體學市場：依應用分類

  • 介紹
  • 農業和植物科學
  • 診斷
  • 藥物發現
  • 精準醫療

第 9 章 多組體學市場：依最終使用者分類

  • 介紹
  • 學術研究所
  • 生技公司
    • 農業
    • 環境科學
    • 法醫學
    • 植物和動物育種
  • 醫院/診所
  • 製藥和生物製藥公司

第10章美洲多組體學市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太多組體學市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的多組體學市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • MultiOmic Health 完成 620 萬美元資金籌措，用於開發METABOLIC INC.症候群相關疾病的精準藥物
    • Biomodal 宣布新的多組體學定序技術
    • Tempus 宣布與 Actuate Therapeutics 開展新的多組體學合作
    • BD 推出高性能單細胞多組體學平台以擴大科學發現的範圍
  • 戰略分析和建議

公司名單

  • 10x Genomics, Inc.
  • AstraZeneca PLC
  • Becton, Dickinson and Company
  • Berkeley Lights, Inc.
  • BGI Genomics Co. Ltd
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • BioLegend, Inc. by PerkinElmer, Inc.
  • Celsee
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • Dolomite Bio by Unchained Labs
  • EpiCypher, Inc.
  • Google LLC by Alphabet Inc.
  • Illumina, Inc.
  • Miltenyi BIoTec
  • Mission Bio, Inc.
  • Multiomic Health Limited
  • NanoCellect Biomedical
  • NanoString Technologies, Inc.
  • Novo Nordisk A/S
  • Olink Proteomics AB
  • QIAGEN NV
  • Shimadzu Corporation
  • Singleron BIoTechnologies GmbH
  • Standard BioTools Inc.
  • TAKARA BIO INC.
  • Tempus Labs, Inc.
  • Thermo Fischer Scientific Inc.
Product Code: MRR-CF699CF41428

The Multiomics Market was valued at USD 83.55 billion in 2023, expected to reach USD 96.86 billion in 2024, and is projected to grow at a CAGR of 16.26%, to USD 239.92 billion by 2030.

Multiomics is a comprehensive approach within the field of biological research that integrates multiple "omics" technologies, such as genomics, transcriptomics, proteomics, and metabolomics, to provide an all-encompassing view of the molecular constituents of cells, tissues, and organisms. The necessity of multiomics arises from the complex nature of biological systems and the need to understand how different molecular components interact and contribute to health and disease states. Its applications span personalized medicine, biomarker discovery, drug development, and agriculture.

KEY MARKET STATISTICS
Base Year [2023] USD 83.55 billion
Estimated Year [2024] USD 96.86 billion
Forecast Year [2030] USD 239.92 billion
CAGR (%) 16.26%

The end-use scope includes pharmaceuticals, biotechnology companies, research institutions, hospitals, and clinics. Multiomics has proven essential for advancing precision medicine, allowing for more targeted therapies and personalized treatment plans, while playing a pivotal role in drug discovery and therapeutic development. Moreover, it helps in agricultural biotechnology by enhancing crop breeding and resilience, contributing significantly to food security.

Market growth factors include advancements in omics technologies, increased investment in research and development, the prevalence of chronic diseases, and a growing emphasis on personalized healthcare. Key opportunities can be found in the rising demand for precision medicine, emerging markets, and the integration of artificial intelligence with multiomics data for enhanced analytics. Expanding partnerships between academic institutions and biotechnology firms could also offer a significant boost.

However, market growth faces challenges such as high costs associated with omics technologies, complex data interpretation, and the need for high-level bioinformatics expertise. Privacy concerns and regulatory constraints further complicate multiomics research and application.

Innovation and research could focus on developing more cost-effective and scalable omics technologies, improving data integration methods, and enhancing bioinformatics tools for better data analysis. Optimizing these areas would address existing challenges and drive market expansion. Despite the competitive nature of the market, there remains potential for significant growth by focusing on emerging fields such as systems biology and by fostering collaborations across sectors to harness collective expertise and leverage emerging technologies.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Multiomics Market

The Multiomics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing advancements in NGS, mass spectrometry-based proteomics, and gene expression profiling platforms
    • High potential owing to a growing preference towards personalized medicines
    • Rising research & development activities conducted by biotechnology companies
  • Market Restraints
    • High cost and limited skilled professionals associated with multiomics
  • Market Opportunities
    • Growing integration of advanced technologies into multiomics
    • Increasing investments in agriculture research and environmental science with sustainability targets
  • Market Challenges
    • Limited standard protocols for data acquisition, storage, and sharing across omics studies

Porter's Five Forces: A Strategic Tool for Navigating the Multiomics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Multiomics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Multiomics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Multiomics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Multiomics Market

A detailed market share analysis in the Multiomics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Multiomics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Multiomics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Multiomics Market

A strategic analysis of the Multiomics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Multiomics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., AstraZeneca PLC, Becton, Dickinson and Company, Berkeley Lights, Inc., BGI Genomics Co. Ltd, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BioLegend, Inc. by PerkinElmer, Inc., Celsee, Charles River Laboratories International, Inc., Danaher Corporation, Dolomite Bio by Unchained Labs, EpiCypher, Inc., Google LLC by Alphabet Inc., Illumina, Inc., Miltenyi Biotec, Mission Bio, Inc., Multiomic Health Limited, NanoCellect Biomedical, NanoString Technologies, Inc., Novo Nordisk A/S, Olink Proteomics AB, QIAGEN N.V., Shimadzu Corporation, Singleron Biotechnologies GmbH, Standard BioTools Inc., TAKARA BIO INC., Tempus Labs, Inc., and Thermo Fischer Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Multiomics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables, Instrument, and Software.
  • Based on Type, market is studied across Epigenomics, Genomics, Metabolomics, Microbiomics, Proteomics, and Transcriptomics.
  • Based on Application, market is studied across Agriculture & Plant Science, Diagnostics, Drug Discovery, and Precision Medicine.
  • Based on End-User, market is studied across Academic & Research Institutes, Biotechnology Companies, Hospitals & Clinics, and Pharmaceutical & Biopharmaceutical Companies. The Biotechnology Companies is further studied across Agriculture, Environmental Science, Forensics, and Plant & Animal Breeding.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing advancements in NGS, mass spectrometry-based proteomics, and gene expression profiling platforms
      • 5.1.1.2. High potential owing to a growing preference towards personalized medicines
      • 5.1.1.3. Rising research & development activities conducted by biotechnology companies
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and limited skilled professionals associated with multiomics
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing integration of advanced technologies into multiomics
      • 5.1.3.2. Increasing investments in agriculture research and environmental science with sustainability targets
    • 5.1.4. Challenges
      • 5.1.4.1. Limited standard protocols for data acquisition, storage, and sharing across omics studies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Multiomics Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Instrument
  • 6.4. Software

7. Multiomics Market, by Type

  • 7.1. Introduction
  • 7.2. Epigenomics
  • 7.3. Genomics
  • 7.4. Metabolomics
  • 7.5. Microbiomics
  • 7.6. Proteomics
  • 7.7. Transcriptomics

8. Multiomics Market, by Application

  • 8.1. Introduction
  • 8.2. Agriculture & Plant Science
  • 8.3. Diagnostics
  • 8.4. Drug Discovery
  • 8.5. Precision Medicine

9. Multiomics Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Biotechnology Companies
    • 9.3.1. Agriculture
    • 9.3.2. Environmental Science
    • 9.3.3. Forensics
    • 9.3.4. Plant & Animal Breeding
  • 9.4. Hospitals & Clinics
  • 9.5. Pharmaceutical & Biopharmaceutical Companies

10. Americas Multiomics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Multiomics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Multiomics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. MultiOmic Health Closes USD 6.2 Million Funding Round to Discover Precision Medicines for Metabolic Syndrome-Related Conditions
    • 13.3.2. Biomodal Launches New Multiomics Sequencing Technology
    • 13.3.3. Tempus Announces New Multi-omics Collaboration with Actuate Therapeutics
    • 13.3.4. BD Introduces High-Throughput Single-Cell Multiomics Platform to Expand Scope of Scientific Discovery
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 10x Genomics, Inc.
  • 2. AstraZeneca PLC
  • 3. Becton, Dickinson and Company
  • 4. Berkeley Lights, Inc.
  • 5. BGI Genomics Co. Ltd
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Bio-Techne Corporation
  • 8. BioLegend, Inc. by PerkinElmer, Inc.
  • 9. Celsee
  • 10. Charles River Laboratories International, Inc.
  • 11. Danaher Corporation
  • 12. Dolomite Bio by Unchained Labs
  • 13. EpiCypher, Inc.
  • 14. Google LLC by Alphabet Inc.
  • 15. Illumina, Inc.
  • 16. Miltenyi Biotec
  • 17. Mission Bio, Inc.
  • 18. Multiomic Health Limited
  • 19. NanoCellect Biomedical
  • 20. NanoString Technologies, Inc.
  • 21. Novo Nordisk A/S
  • 22. Olink Proteomics AB
  • 23. QIAGEN N.V.
  • 24. Shimadzu Corporation
  • 25. Singleron Biotechnologies GmbH
  • 26. Standard BioTools Inc.
  • 27. TAKARA BIO INC.
  • 28. Tempus Labs, Inc.
  • 29. Thermo Fischer Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. MULTIOMICS MARKET RESEARCH PROCESS
  • FIGURE 2. MULTIOMICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MULTIOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MULTIOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MULTIOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MULTIOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MULTIOMICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MULTIOMICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MULTIOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MULTIOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MULTIOMICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL MULTIOMICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES MULTIOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES MULTIOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. MULTIOMICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. MULTIOMICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MULTIOMICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MULTIOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MULTIOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MULTIOMICS MARKET DYNAMICS
  • TABLE 7. GLOBAL MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MULTIOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MULTIOMICS MARKET SIZE, BY INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MULTIOMICS MARKET SIZE, BY EPIGENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MULTIOMICS MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MULTIOMICS MARKET SIZE, BY METABOLOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MULTIOMICS MARKET SIZE, BY MICROBIOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MULTIOMICS MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MULTIOMICS MARKET SIZE, BY TRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MULTIOMICS MARKET SIZE, BY AGRICULTURE & PLANT SCIENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MULTIOMICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MULTIOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MULTIOMICS MARKET SIZE, BY PRECISION MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MULTIOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL MULTIOMICS MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL MULTIOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL MULTIOMICS MARKET SIZE, BY FORENSICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL MULTIOMICS MARKET SIZE, BY PLANT & ANIMAL BREEDING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL MULTIOMICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL MULTIOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES MULTIOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. INDONESIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. JAPAN MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. JAPAN MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. MALAYSIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. MALAYSIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. PHILIPPINES MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. PHILIPPINES MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SINGAPORE MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. SINGAPORE MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. SOUTH KOREA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. SOUTH KOREA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. TAIWAN MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. TAIWAN MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. THAILAND MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. THAILAND MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. VIETNAM MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. VIETNAM MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. DENMARK MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. DENMARK MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. EGYPT MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. EGYPT MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FINLAND MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. FINLAND MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. FRANCE MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. FRANCE MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. GERMANY MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. GERMANY MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ISRAEL MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. ISRAEL MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. ITALY MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. ITALY MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NETHERLANDS MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. NETHERLANDS MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NIGERIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. NIGERIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. NORWAY MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. NORWAY MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. POLAND MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. POLAND MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. QATAR MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. QATAR MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. RUSSIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. RUSSIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SAUDI ARABIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. SAUDI ARABIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SOUTH AFRICA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. SOUTH AFRICA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SPAIN MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. SPAIN MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWEDEN MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. SWEDEN MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. SWITZERLAND MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. SWITZERLAND MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. TURKEY MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. TURKEY MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED ARAB EMIRATES MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED ARAB EMIRATES MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. UNITED KINGDOM MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 242. MULTIOMICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 243. MULTIOMICS MARKET, FPNV POSITIONING MATRIX, 2023